FdaApplication
ANDA 207411
Identifiers
- fda_app_no: ANDA207411
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2019-03-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | 0.05% | SOLUTION/DROPS;OPHTHALMIC |
1 product